This inventor holds 1 USPTO granted patent. Top assignees: Queensland Institute of Medical Research, Southern Adelaide Local Health Network, The Trustees of Flinders University. Active years: 2025.
Company Filing History:
1 out of 31 
1 out of 1 
1 out of 29 
Years Active: 2025
Title: Alex William Hewitt: Innovator in Glaucoma Risk Assessment
Introduction
Alex William Hewitt is a notable inventor based in Bonnet Hill, Australia. He has made significant contributions to the field of medical research, particularly in the assessment of glaucoma risk. His innovative approach combines genetic analysis with clinical assessments to provide a comprehensive understanding of glaucoma susceptibility.
Latest Patents
Hewitt holds a patent for "Methods and systems for assessing the risk of glaucoma." This patent outlines a method for determining a risk score for primary open angle glaucoma based on the genetic content of a subject at various selected genetic loci or markers. The method assesses the risk by considering genetic associations with glaucoma, increased intraocular pressure, and other relevant traits. This innovative approach has the potential to enhance early detection and management of glaucoma.
Career Highlights
Throughout his career, Hewitt has worked with esteemed institutions such as the Trustees of Flinders University and the Queensland Institute of Medical Research. His work has focused on integrating genetic research with clinical practices to improve patient outcomes in ophthalmology.
Collaborations
Hewitt has collaborated with notable colleagues, including Jamie Evan Craig and Stuart MacGregor. These partnerships have fostered advancements in glaucoma research and have contributed to the development of effective assessment methods.
Conclusion
Alex William Hewitt's contributions to glaucoma risk assessment through his innovative patent demonstrate his commitment to advancing medical research. His work not only enhances our understanding of glaucoma but also paves the way for improved patient care.